On Feb. 1, 2021, Dynavax Technologies announced Valneva had informed it that the UK Government exercised its option…
On Feb. 1, 2021, Pfizer and BioNTech announced that preclinical data in non-human primate and mouse models from…
On Jan. 31, 2021, Sorrento Therapeutics announced additional positive results from its Phase 1b study of human allogeneic…
On Jan. 30, 2021, as the COVID-19 pandemic continued to surge in the U.S., the CDC implemented a…
On Jan. 29, 2021, Rigel Pharma announced it has been awarded $16.5 million by the U.S. Department of…
On Jan. 29, 2021, Humanigen announced it had completed enrollment for its pivotal phase 3 study of lenzilumab…
On Jan. 29, 2021, Innovation Pharmaceuticals announced that the companyï¾’s Phase 2 clinical trial of Brilacidin for treating…
On Jan. 29, 2021, Johnson & Johnson announced topline efficacy and safety data from the Phase 3 ENSEMBLE…
On Jan. 29, 2021, Pfizer and BioNTech announced that data from an in vitro study on the capability…
On Jan. 29, 2021, OraSure Technologies announced its OMNIgeneﾮﾷORAL (OM-505) saliva collection kit, a product of subsidiary DNA…
On Jan. 28, 2021, National Institutes of Health (NIH) researchers reported that pregnant women who experienced severe symptoms…
On Jan. 28, 2021, scientists at the National Eye Institute (NEI) have developed a promising gene therapy strategy…
On Jan. 28, 2021, The WHO announced that COVID-19 cases and deaths were surging in Africa as more…
On Jan. 28, 2021, the CDC announced that it had become aware of the first U.S. documented cases…
On Jan 28, 2021, Mammoth Biosciences announced a co-marketing agreement with Agilent Technologies to support the anticipated launch…
On Jan. 28, 2021, Precipio announced that following receipt of an Emergency Use Authorization from the U.S. Food…
On Jan. 28, 2021, Novavax announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with…
On Jan. 28, 2021, Celsion announced the filing of a provisional U.S. patent application for a novel DNA-based,…
On Jan. 28, 2021, OraSure Technologies announced its OMNIgeneﾮﾷORAL (OME-505) saliva collection device, a product of Ottawa-based subsidiary…
On Jan. 27, 2021, a CDC study found that the 2019-2020 flu vaccine provided significant protection against flu-associated…
On Jan. 27, 2021, Vaxart announced health care economic findings published in the American Journal of Preventative Medicine….
On Jan. 27, 2021, Ajinomoto Bio-Pharma Services and Humanigen announced the companies will be expanding their manufacturing agreement…
On Jan. 27, 2021, OncoSec Medical announced that it had dosed several subjects in its Phase 1 clinical…
On Jan. 27, 2021, Eli Lilly, Vir Biotechnology and GlaxoSmithKline announced a collaboration to evaluate a combination of…
On Jan. 27, 2021, Moderna confirmed that the Company is in discussion with the U.S. government to purchase…
On Jan. 27, 2021, researchers at the Broad Institute of MIT and Harvard, and Massachusetts General Hospitalï¾’s Center…
On Jan. 27, 2021, Heat Biologics announced the publication of additional preclinical COVID-19 results in Frontiers in Immunology,…
On Jan. 27, 2021, researchers in Dr. David Ho’s Columbia University lab and Regeneron scientists announced they had…
On Jan. 27, 2021, Pfizer and BioNTech announced results from in vitro neutralization studies of sera from individuals…
On Jan. 26, 2021, NIH researchers announced that an investigational anti-HIV antibody delivered intravenously once every eight weeks…